<PAGE> 1
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
1. Name and Address of Reporting Person:
David Knudson, 1661 Lakeview Circle, Ogden, UT 84403
2. Issuer Name and Ticker or Trading Symbol:
ImmunoTechnology Corp (IMNT.OB)
3. IRS or Social Security Number of Reporting Person (Voluntary):
4. Statement for Month/Year: 6/2000
5. If Amendment, Date of Original (Month/Year):
6. Relationship of Reporting Person(s) to Issuer (Check all Applicable)
( ) Director (X) Officer, give title below ( ) 10% Owner ( ) Other
Title: Secretary/Treasurer
7. Individual or Joint/Group Filing (Check Applicable Line)
(X) Form filed by One Reporting Person
( ) Form filed by More than One Reporting Person
TABLE I
NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
1. Title of Security: Common Stock
2. Transaction Date (Month/Day/Year): 06/21/2000
3. Transaction Code: J
4. Securities Acquired (A) or Disposed of (D): Amount: (A) 1,115,673
5. Amount of Securities Beneficially Owned at End of Month: 1,117,673
6. Ownership Form: Direct (D) or Indirect (I): (D)
7. Nature of Indirect Beneficial Ownership: N/A
TABLE II
DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF OR BENEFICIALLY OWNED
1. Title of Derivative Security:
2. Conversion or Exercise Price of Derivative Security:
3. Transaction Date (Month/Day/Year):
4. Transaction Code:
5. Number of Derivative Securities Acquired (A) or Disposed of (D):
6. Date Exercisable and Expiration Date (Month/Day/Year):
7. Title and Amount of Underlying Securities:
8. Price of Derivative Security:
9. Number of Derivative Securities Beneficially Owned at End of Month:
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I):
11. Nature of Indirect Beneficial Ownership:
Explanation of Responses: The securities were acquired in settlement of debt
owed to Mr. Knudson totaling $34,864.78 in principal and interest.
Signature of Reporting Person: /S/David Knudson
Date: 7/5/2000
